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Abstract
Background: Contrast sensitivity (CS) is widely used as a measure of visual function in research and clinical settings.
CS is regarded as an important visual parameter, detecting subtle reductions in vision prior to significant reduction in
visual acuity. Methods: We examined the agreement between the gold-standard Pelli–Robson chart and a computerized
test termed the M&S Smart System II (MSSS-II) in patients with primary pterygium. Ninety-three patients (93 primary
pterygium eyes) who visited an ophthalmology clinic were selected. The patients were randomly assessed for CS using
the MSSS-II or Pelli–Robson chart. The primary outcome was agreement in log units between these two tests in the
assessment of CS in patients with primary pterygium. Results: The mean and standard deviation of CS measurement in
the two tests were comparable (1.22 ± 0.56 vs. 1.21 ± 0.57 log units, respectively, p = 0.083). The Bland–Altman plot
revealed that the mean difference between the two charts was 0.0016 log units (standard deviation: 0.009 log units) with
narrow limits of agreement of −0.0186 to 0.0186. Conclusions: MSSS-II provides an alternative for the clinical
assessment of CS using a computerized method that describes the status of visual function in patients with primary
pterygium.
Keywords: contrast sensitivity, Pelli–Robson chart, M&S Smart System II, pterygium

of luminance from the background.3,4 Assessment of CS
provides valuable information for the early detection and
monitoring of certain ocular diseases such as amblyopia,5,6
cataract,7,8 glaucoma,9-12 macular degeneration,11 diabetic
retinopathy,13,14,15 as well as the evaluation of therapeutic
outcomes.16 In addition, CS is often considered a better
indicator for functional disabilities17,18 and predictive of
performance impairment compared with standard acuity
measurements.19-22 Clinically, CS has commonly been
assessed using the established Pelli–Robson chart
(Clement Clarke Inter-national, Essex, UK).23 However,
there is a limitation in logistic and chart fades over time
that makes this chart portable due to its specific
requirements such as illumination.

Introduction
Pterygium is a disorder characterized by abnormal
fibrovascular growth, originating from the bulbar
conjunctiva and progressing towards the central cornea.
It is estimated that the prevalence of pterygium is higher
in geographical locations near the equator. Although
standard clinical techniques, such as best-corrected
visual acuity (BCVA), are widely used for the
assessment of visual performance in patients with
pterygium, the use of a clinical parameter – contrast
sensitivity (CS) – has rarely been addressed. Previous
research has shown that BCVA alone may be
inadequate in assessing visual impairment in patients
with pterygium, as the effect of CS on visual
performance occurs prior to reduction in the BCVA.1,2

The M&S Smart System II (MSSS-II; M&S Technologies
Inc., Niles, IL, USA) comprises a combination of
computer-generated, letter-based CS tests. The luminance
of the liquid crystal display screen can be adjusted to the
recommended level of luminance (85 candelas/m2)

CS refers to a measurement of visual function – specifically
based on variation in luminance (i.e., brightness) – used
to distinguish between visible and invisible increments
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using its built-in control. The testable contrast of the
MSSS-II ranges from 0.0 to 2.3 log units (comparable with
the Pelli–Robson chart), with each level corresponding
to a change of 0.1 log units. This system offers several
advantages over the Pelli–Robson chart such as
conducting the test in dark illumination, calibrating the
test at various distances, and using random letters that
prevent patients from memorizing their position.
Previous studies had reported that the measurement of
CS using the MSSS-II is comparable with that of the
Pelli–Robson chart in healthy adults and children24 and
in glaucoma patients.11,12 However, to the best of our
knowledge, there is no evidence on the reliability of CS
testing using the MSSS-II in patients with primary
pterygium. Therefore, we aimed to determine the
reliability of the MSSS-II in comparison with the Pelli–
Robson chart for measuring CS in such patients.

Methods
A total of 93 patients with primary pterygium were
selected to participate in this study. All patients in this
study were selected on the basis of specific criteria. The
inclusion criteria involved an established diagnosis of
primary pterygium by a consultant ophthalmologist
(KMK). The study included male and female patients
aged 20 to 70 years and free from a history of ocular
trauma, ocular surgery, use of a contact lens, or any
ocular anterior segment disease other than pterygium
that may affect vision, as previously described.25 The
sample size was calculated using the mean difference
between preoperative and postoperative (3 months after
for the treatment of pterygium) corneal astigmatism, as
previously reported.26 The Power and Sample Size
Calculation software (Version 3.1.2) (PS software,
Nashville, TN, USA) was used for this purpose.27

score of 0.05 for each correct response.30 For the MSSSII, patients were requested to identify the letter
displayed in the center of the screen. Subsequently, the
operator adjusted the contrast level based on the
previous response. A single Sloan letter with 100%
contrast level was set as the baseline. Once the patient
approached the threshold, determined by hesitation in
response or error in identifying the letter, the operator
randomly selected two Sloan letters at the same contrast
level to be correctly identified by each patient prior to
determining the contrast threshold.24
Statistical analyses were performed using IBM SPSS
(Predictive analytics software) (Version 24, SPSS Inc.,
Chicago, IL, USA). The primary outcome of this study
was the agreement between the MSSS-II and the Pelli–
Robson chart in patients with primary pterygium. The
agreement between these two tests was assessed via the
paired t-test and the Bland–Altman plot.31,32

Results
Of the 93 patients in the analysis, 50.5% (n = 47) were
male. The mean ± standard deviation for age, CS
(MSSS-II), and CS (Pelli–Robson chart) were 57.42 ±
11.55 years, 1.22 ± 0.56 log units, and 1.21 ± 0.57 log
units, respectively. The results of the paired t-test showed
that the difference between the MSSS-II and the Pelli–
Robson chart were not statistically significant (p = 0.083).
The Bland–Altman analysis showed excellent agreement
between the tests with a mean difference in CS of 0.0016
log units and narrow limits of agreement of 0.037.
Figure 1 illustrates the agreement between the two tests
using the Bland–Altman plot.

The study was conducted in accordance with the tenets
of the Declaration of Helsinki and approved by the
ethical research committee (IIUM/310/G13/4/4-125) of
the International Islamic University Malaysia. Written
informed consent was provided by all patients prior to
their participation in this study. The CS function and
BCVA were measured using the M&S Technologies
Smart System II (SSII, Park Ridge, IL, USA). The
setting of this system was similar to that described in
previous studies.24,28 The patients were randomized
using a randomization software29 prior to undergoing
testing using the Pelli–Robson chart or the MSSS-II.
The size of the MSSS-II optotype was set at 1.5
logarithms of the minimum angle of resolution at a
distance of 4 m, to ensure it is comparable with the
visual angle subtended by letters presented on the Pelli–
Robson chart at 1 m, hence representing a spatial
frequency of one cycle per degree for both distances.
The patients assessed via the Pelli–Robson chart were
scored individually for each letter, with an assigned
Makara J. Health Res.

Figure 1. Bland–Altman plots of the difference in CS between
the Pelli–Robson chart and MSSS-II to their mean. Mean
difference of CS between the tests was 0.0016 (SD: 0.008),
and the 95% limits of agreement were 0.0186 to −0.0186. SD
= standard deviation; CS = contrast sensitivity; MSSS-II =
M&S Smart System II
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Discussion
The importance of assessing CS in patients with primary
pterygium has rarely been addressed. Moreover, the
impact of pterygium on oculo-visual function cannot be
easily described. This is attributed to an association
between visual quality and changes in visual acuity and
corneal curvature (known as k-reading). Although visual
acuity has been extensively investigated, CS is rarely
discussed as a component of visual quality assessment
in patients with primary pterygium. In 1997, Tan et al.33
proposed a clinical grading system based on the
translucent appearance of the pterygium tissue,
corresponding to an increase of fleshiness of the
fibrovascular components of the pterygium. Previous
studies demonstrated that translucency (fleshiness) of
the pterygium exerts various effects on visual performance.25 This is important as a reduction of CS may
occur, irrespective of visual acuity impairment.22,25,34–38
Different types of pterygia exert different effects in CS
due to variations in their fleshiness. However, based on
the Pelli–Robson chart, the simultaneous assessment of
BCVA and CS is challenging. Hence, it is inconvenient
for patients to undergo assessment of both components.
Our study demonstrated that the MSSS-II provides
comparable measurements of CS and BCVA with those
obtained using the Pelli–Robson chart, when measured
simultaneously. In addition, this was supported by the
narrow limits of agreement observed in this analysis.
Previous studies32 have shown that limits of agreement
<1.0 are indicative of good agreement between two
tests.
It is postulated that these variations may be due to the
difference in log progression between these two charts.
The log progressions were smaller with the MSSS-II
compared with those observed with the Pelli–Robson
chart (0.10 vs. 0.15 log units, respectively). Moreover,
the testing time for the MSSS-II system was shorter
compared with that of the Pelli–Robson chart, which
further minimizes variations in measurement. The
shorter testing time observed with MSSS-II is attributed
to its requirement of only one letter for each contrast
level. In contrast, the Pelli–Robson chart requires all
three letters in a triplet for each contrast level.
The present findings showed lower value for CS
function compared with that reported in previous
studies.39 This may be due to two reasons. Firstly, the
present study included patients with primary pterygium,
whereas the previous study24 involved healthy young
adults. It is expected that young and healthy adults may
exhibit better CS compared with that observed in
patients with a visible anterior eye lesion (e.g.,
pterygium). Any obstacle on the cornea would result in
an abnormal CS. Secondly, the approximately equal
distribution of patients in this study may have resulted
Makara J. Health Res.

in a lower CS as different types of pterygium may affect
the measurement due to their fleshy appearance, which
indirectly affects visual performance.
The MSSS-II offers several advantages over the Pelli–
Robson chart. There are several factors that may affect
the measurement of the CS threshold using the Pelli–
Robson chart. Firstly, the recommended luminance of
85 candelas/m2 (range: 60–120 candelas/m2) for the
Pelli–Robson chart is difficult to be used in a clinical
setting as the illumination in the lower portion of the
chart decreases in parallel with the overhead lighting
compared with that in the top portion. Moreover,
different rooms with different light fixtures may cause
variations in the measurement of the threshold.
Secondly, the Pelli–Robson chart fades over time with
exposure. According to the recommendations of the
manufacturer, the chart should be replaced every 7
years. Thus, the use of the Pelli–Robson chart would be
an issue regarding its variations and accuracy when
comparing measurements of different ages. A lack of
standardization in CS measurements may occur because
of faded chart. Thirdly, the Pelli–Robson chart includes
only two versions with different triplets of optotypes.
Hence, repetitive testing may lead to memorizing of
frequently used letters, especially those that are tested
approximately at their threshold.

Conclusions
The present findings showed that the MSSS-II may be
used as a clinical alternative to the Pelli–Robson chart
for the measurement of CS, during the assessment of
visual function in patients with primary pterygium.

Acknowledgements
This research was financially supported by the Ministry
of Science, Technology and Innovation Malaysia under
the Fundamental Research Grant Scheme (FRGS)
FRGS14-138-0379 and International Islamic University
Malaysia under the Research Initiative Grant Scheme
RIGS17-148-0723.

Conflict of interest
The author report no conflict of interest.

References
1.
2.

Malik A, Arya SK, Sood S, Sarda SB, Narang S. Effect of
pterygium on contrast sensitivity. Int Ophthalmol.
2014;34:505-9.
Koh S, Maeda N, Ikeda C, Asonuma S, Ogawa M,
Hiraoka T, et al. The effect of ocular surface regularity on
contrast sensitivity and straylight in dry eye. Invest
Ophthalmol Vis Sci. 2017;58:2647-51.

December 2018 | Vol. 22 | No. 3

170 Khairidzan, et al.

3.

4.
5.
6.

7.

8.
9.

10.

11.
12.

13.

14.
15.

16.

17.
18.

19.

Wei H, Sawchyn AK, Myers JS, Katz LJ, Moster MR,
Wizoy SS, et al. A clinical method to assess the effect of
visual loss on the ability to perform activities of daily
living. Br J Ophthalmol. 2012;95:735-41.
Pelli DG, Bex P. Measuring contrast sensitivity. Vision
Res. 2013;90:10-4.
Pang Y, Allen M, Robinson J, Frantz KA. Contrast
sensitivity of amblyopic eyes in children with myopic
anisometropia. Clin Exp Optom. 2018.
Barollo M, Contemori G, Battaglini L, Pavan A, Casco C.
Perceptual learning improves contrast sensitivity, visual
acuity, and foveal crowding in amblyopia. Restor Neurol
Neurosci. 2017;35:483-96.
Chiche A, Trinh L, Saada O, Faure JF, Auclin F,
Baudouin C, et al. Early recovery of quality of vision and
optical performance after refractive surgery: Small-incision
lenticule extraction versus laser in situ keratomileusis. J
Cataract Refract Surg. 2018;44:1073-79.
Paz-Filgueira C, Colombo EM. Quantifying the effect of
straylight on photopic contrast sensitivity. J Opt Soc Am
A Opt Image Sci Vis. 2018;35:1124-30.
Bierings RAJM, Kuiper M, van Berkel CM, Overkempe
T, Jansonius NM. Foveal light and dark adaptation in
patients with glaucoma and healthy subjects: A casecontrol study. PLoS One. 2018;13:e0193663.
Lin S, Mihailovic A, West SK, Johnson CA, Friedman
DS, Kong X, et al. Predicting visual disability in
glaucoma with combinations of vision measures. Transl
Vis Sci Technol. 2018;7:22.
Pelli DG, Robson JG, Wilkins AJ. The design of a new
letter chart for measuring contrast sensitivity. Clin Vis
Sci. 1988;2:187-99.
Fatehi N, Nowroozizadeh S, Henry S, Coleman AL,
Caprioli J, Nouri-Mahdavi K. Association of structural
and functional measures with contrast sensitivity in
glaucoma. Am J Ophthalmol. 2017;178:129-39.
Roh M, Selivanova A, Shin HJ, Miller JW, Jackson ML.
Visual acuity and contrast sensitivity are two important
factors affecting vision-related quality of life in advanced
age-related macular degeneration. PLoS One. 2018;13:
e0196481.
Safi H, Safi S, Hafezi-Moghadam A, Ahmadieh H. Early
detection of diabetic retinopathy. Surv Ophthalmol.
2018;63:601-8.
Hautala N, Siiskonen M, Hannula V, Järvinen K, Falck
A. Early glycaemic control for maintaining visual
function in type 1 diabetes: The Oulu cohort study of
diabetic retinopathy. Eur J Ophthalmol. 2018:
1120672117750053.
Okamoto Y, Okamoto F, Hiraoka T, Oshika T. Visionrelated quality of life and visual function following
intravitreal bevacizumab injection for persistent diabetic
macular edema after vitrectomy. Jpn J Ophthalmol.
2014;58:369-74.
Owsley C. Contrast sensitivity. Ophthalmol Clin North
Am. 2003;16:171-7.
Wittich W, Lorenzini M-C, Markowitz SN, Tolentino M,
Gartner SA, Goldstein JE, et al. The effect of a headmounted low vision device on visual function. Optom Vis
Sci. 2018;95:774-84.
Hasanov S, Demirkilinc BE, Acarer A, Akkın C,
Colakoglu Z, Uretmen O. Functional and morphological
assessment of ocular structures and follow-up of patients

Makara J. Health Res.

20.
21.

22.
23.

24.

25.

26.

27.

28.
29.

30.
31.
32.
33.
34.

35.

36.

with early-stage Parkinson's disease. Int Ophthalmol.
2018:1-8.
Savini G, Balducci N, Carbonara C, Rossi S, Altieri M,
Frugis N. Functional assessment of a new extended
depth-of-focus intraocular lens. Eye. 2018:1.
Lin HT, Chan HJ, Ho CW, Tai MC, Chen JT, Liang CM.
Impact of hypoxic and mesopic environments on visual
acuity, contrast sensitivity and accommodation in subjects
with LASIK surgery and aircrew candidate. J Chin Med
Assoc. 2018: S1726-490130230-2.
Ginsburg, AP. Contrast sensitivity and functional vision.
Int Ophthalmol Clin. 2003;43:5-15.
Thurman SM, Davey PG, McCray KL, Paronian V, Seitz
AR. Predicting individual contrast sensitivity functions
from acuity and letter contrast sensitivity measurements.
J Vis. 2016;16:1-15.
Liu JL, McAnany JJ, Wilensky JT, Aref AA, Vajaranant
TS. M&S Smart System contrast sensitivity measurements
compared with standard visual function measurements in
primary open-angle glaucoma patients. J Glaucoma.
2017;26:528-33.
Chandrakumar M, Colpa L, Reginald YA, Goltz HC,
Wong AMF. Measuring contrast sensitivity using the
M&S Smart System II versus the Pelli-Robson chart.
Ophthalmology. 2013;120:2160-1.
Mohd Radzi H, Mohd Zulfaezal CA, Khairidzan MK,
Mohd Izzuddin MT, Norfazrina AG, Tengku Mohd TS.
Prediction of changes in visual acuity and contrast
sensitivity function by tissue redness after pterygium
surgery. Curr Eye Res. 2017;42:852-6.
Altan-Yaycioglu R, Kucukerdonmez C, Karalezli A,
Corak F, Akova YA. Astigmatic changes following
pterygium removal: comparison of 5 different methods.
Indian J Ophthalmol. 2013;61:104-8.
Dupont WD, Plummer WD. Power and sample size
calculations for studies involving linear regression.
Controlled Clinical Trials. 1998;19:589-601.
McClenaghan N, Kimura A, Stark LR. An evaluation of
the M&S technologies smart system II for visual acuity
measurement in young visually-normal adults. Optom Vis
Sci. 2007;84:218-23.
Urbaniak GC, Plous S. Research Randomizer (Version 4.0)
[computer software]. Available at: http://www.randomizer.
org/. Accessed at June 19th 2013.
Elliot DB, Whitaker D. Clinical contrast sensitivity chart
evaluation. Ophthalmic Physiol Opt. 1992;12:275-80.
Bland JM, Altman DG. Statistical methods for assessing
agreement between two methods of clinical measurement.
Lancet. 1986;327:307-10.
Bland JM, Altman DG. Agreement between methods of
measurement with multiple observations per individual. J
Biopharm Stat. 2007;17:571-82.
Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium
morphology on pterygium recurrence in a controlled trial
comparing conjunctival autografting with bare sclera
excision. Arch Ophthalmol. 1997;115:1235-40.
Fatehi N, Nowroozizadeh S, Henry S, Coleman AL,
Caprioli J, Nouri-Mahdavi K. Association of structural
and functional measures with contrast sensitivity in
glaucoma. Am J Ophthalmol. 2017;178:129-39.
Amanullah S, Okudolo J, Rahmatnejad K, Lin SC, Wizov
SS, Muhire RS, et al. The relationship between contrast
sensitivity and retinal nerve fiber layer thickness in patients

December 2018 | Vol. 22 | No. 3

Measurement of Contrast Sensitivity Using the M & S 171

with glaucoma. Graefes Arch Clin Exp Ophthalmol.
2017;255:2415-22.
37. Woods R, Wood J. The role of contrast sensitivity charts
and contrast letter charts in clinical practice. Clin Exp
Optom. 1995;78:43-57.
38. Oh JY, Wee WR. The effect of pterygium surgery on
contrast sensitivity and corneal topographic changes. Clin
Ophthalmol. 2010;4:315-9.

Makara J. Health Res.

39. Sandra S, Zeljka J, Zeljka V, Kristian S, Ivana A. The
influence of pterygium morphology on fibrin glue
conjunctival autografting pterygium surgery. Int
Ophthalmol. 2014;34:75-9.

December 2018 | Vol. 22 | No. 3

